Virijevic, M. et al. 2016. Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukemia with normal karyotype. Radiology and Oncology. 50, 4 (Nov. 2016).